Thomasville National Bank Sells 485 Shares of Clorox Co (NYSE:CLX)

Share on StockTwits

Thomasville National Bank lowered its holdings in shares of Clorox Co (NYSE:CLX) by 12.3% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 3,446 shares of the company’s stock after selling 485 shares during the period. Thomasville National Bank’s holdings in Clorox were worth $724,000 as of its most recent filing with the SEC.

Several other hedge funds have also added to or reduced their stakes in CLX. APG Asset Management N.V. grew its holdings in shares of Clorox by 8,909.5% during the 1st quarter. APG Asset Management N.V. now owns 1,108,615 shares of the company’s stock valued at $158,426,000 after purchasing an additional 1,096,310 shares during the last quarter. FMR LLC grew its holdings in shares of Clorox by 530.5% during the 2nd quarter. FMR LLC now owns 951,642 shares of the company’s stock valued at $208,762,000 after purchasing an additional 800,697 shares during the last quarter. Robeco Institutional Asset Management B.V. grew its holdings in shares of Clorox by 184.5% during the 2nd quarter. Robeco Institutional Asset Management B.V. now owns 671,509 shares of the company’s stock valued at $147,309,000 after purchasing an additional 435,487 shares during the last quarter. Royal Bank of Canada grew its holdings in shares of Clorox by 121.0% during the 1st quarter. Royal Bank of Canada now owns 665,506 shares of the company’s stock valued at $115,298,000 after purchasing an additional 364,310 shares during the last quarter. Finally, Nuveen Asset Management LLC grew its holdings in shares of Clorox by 81.9% during the 2nd quarter. Nuveen Asset Management LLC now owns 707,775 shares of the company’s stock valued at $155,265,000 after purchasing an additional 318,639 shares during the last quarter. 79.18% of the stock is currently owned by institutional investors.

Several brokerages have weighed in on CLX. Zacks Investment Research cut shares of Clorox from a “buy” rating to a “hold” rating and set a $249.00 price target for the company. in a research report on Thursday, August 6th. Morgan Stanley increased their price target on shares of Clorox from $193.00 to $197.00 and gave the company an “underweight” rating in a research report on Tuesday, August 4th. Citigroup increased their price target on shares of Clorox from $206.00 to $246.00 and gave the company a “neutral” rating in a research report on Tuesday, August 4th. Deutsche Bank increased their price target on shares of Clorox from $174.00 to $223.00 and gave the company a “hold” rating in a research report on Monday, July 27th. Finally, JPMorgan Chase & Co. increased their price target on shares of Clorox from $203.00 to $235.00 and gave the company an “overweight” rating in a research report on Thursday, July 16th. Three equities research analysts have rated the stock with a sell rating, eight have issued a hold rating and three have assigned a buy rating to the company. The stock has a consensus rating of “Hold” and a consensus target price of $202.50.

NYSE:CLX opened at $211.65 on Friday. The company has a 50-day moving average price of $217.02 and a 200-day moving average price of $207.94. Clorox Co has a 12 month low of $144.12 and a 12 month high of $239.87. The company has a current ratio of 1.42, a quick ratio of 1.10 and a debt-to-equity ratio of 3.06. The stock has a market cap of $26.48 billion, a price-to-earnings ratio of 28.80, a P/E/G ratio of 3.82 and a beta of 0.27.

Clorox (NYSE:CLX) last issued its quarterly earnings results on Monday, August 3rd. The company reported $2.41 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.00 by $0.41. Clorox had a net margin of 13.97% and a return on equity of 138.70%. The company had revenue of $1.98 billion during the quarter, compared to analysts’ expectations of $1.86 billion. During the same period last year, the company posted $1.88 EPS. Clorox’s revenue was up 21.9% on a year-over-year basis. Equities analysts forecast that Clorox Co will post 7.75 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 20th. Investors of record on Wednesday, November 4th will be given a dividend of $1.11 per share. The ex-dividend date of this dividend is Tuesday, November 3rd. This represents a $4.44 dividend on an annualized basis and a yield of 2.10%. Clorox’s dividend payout ratio (DPR) is currently 60.33%.

In related news, SVP Diego J. Barral sold 10,041 shares of Clorox stock in a transaction dated Tuesday, August 4th. The shares were sold at an average price of $235.59, for a total transaction of $2,365,559.19. Following the completion of the transaction, the senior vice president now directly owns 13,931 shares of the company’s stock, valued at approximately $3,282,004.29. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, SVP Andrew J. Mowery sold 12,932 shares of Clorox stock in a transaction dated Thursday, August 6th. The shares were sold at an average price of $235.97, for a total transaction of $3,051,564.04. Following the transaction, the senior vice president now directly owns 18,456 shares of the company’s stock, valued at $4,355,062.32. The disclosure for this sale can be found here. Company insiders own 1.14% of the company’s stock.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.

Recommended Story: Learning About the VIX – Volatility Index

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Thomasville National Bank Sells 485 Shares of Clorox Co
Thomasville National Bank Sells 485 Shares of Clorox Co
Park National Corp OH Has $1.10 Million Position in Clorox Co
Park National Corp OH Has $1.10 Million Position in Clorox Co
Golden Star Resources  versus The Competition Head to Head Comparison
Golden Star Resources versus The Competition Head to Head Comparison
Moelis & Co  Upgraded to “Neutral” by UBS Group
Moelis & Co Upgraded to “Neutral” by UBS Group
Bed Bath & Beyond  Price Target Increased to $22.00 by Analysts at Raymond James
Bed Bath & Beyond Price Target Increased to $22.00 by Analysts at Raymond James
Capital Bancorp  Upgraded to “Buy” at Zacks Investment Research
Capital Bancorp Upgraded to “Buy” at Zacks Investment Research


 
© 2006-2020 Zolmax.